04/24/2024 7:53 PM | Centessa Pharmaceuticals (Filer)
| Form 424B5 | |
04/24/2024 8:26 AM | Centessa Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/23/2024 4:16 PM | Centessa Pharmaceuticals (Filer)
| Form 424B5 | |
04/22/2024 6:15 AM | Centessa Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/02/2024 3:17 PM | Centessa Pharmaceuticals (Issuer) SAHA SAURABH (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/02/2024 3:15 PM | Bush Tia L (Reporting) Centessa Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/02/2024 3:16 PM | Centessa Pharmaceuticals (Issuer) HUSSAIN IQBAL J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
03/28/2024 3:44 PM | Centessa Pharmaceuticals (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/26/2024 3:16 PM | Anderson Karen M. (Reporting) Centessa Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/25/2024 3:06 PM | Anderson Karen M. (Reporting) Centessa Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2024 4:37 PM | Centessa Pharmaceuticals (Subject) EcoR1 Capital, LLC (Filed by)
| Form SC 13G/A | |
02/09/2024 6:12 AM | Centessa Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/02/2024 4:10 PM | Centessa Pharmaceuticals (Issuer) CHAO DAVID M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 4:02 PM | Anderson Karen M. (Reporting) Centessa Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 4:03 PM | Centessa Pharmaceuticals (Issuer) Rotman Harris (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 4:04 PM | Bush Tia L (Reporting) Centessa Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 4:07 PM | Centessa Pharmaceuticals (Issuer) SAHA SAURABH (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 4:08 PM | Centessa Pharmaceuticals (Issuer) Weinhoff Gregory M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 4:09 PM | Centessa Pharmaceuticals (Issuer) HUSSAIN IQBAL J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/09/2024 6:56 AM | Centessa Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/09/2024 6:56 AM | Centessa Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/02/2024 6:41 PM | Centessa Pharmaceuticals (Issuer) GRAINGER DAVID J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/02/2024 6:43 PM | Centessa Pharmaceuticals (Issuer) SAHA SAURABH (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/02/2024 6:44 PM | Centessa Pharmaceuticals (Issuer) HUSSAIN IQBAL J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/02/2024 6:45 PM | Centessa Pharmaceuticals (Issuer) Weinhoff Gregory M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/02/2024 6:46 PM | Centessa Pharmaceuticals (Issuer) CHAO DAVID M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/02/2024 6:37 PM | Bush Tia L (Reporting) Centessa Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/11/2023 6:05 AM | Centessa Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/25/2023 8:49 AM | Centessa Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/03/2023 3:46 PM | Bush Tia L (Reporting) Centessa Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/22/2023 3:47 PM | Centessa Pharmaceuticals (Issuer) Rotman Harris (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/20/2023 3:02 PM | Centessa Pharmaceuticals (Subject) Rotman Harris (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/01/2023 3:31 PM | Centessa Pharmaceuticals (Subject) YVER ANTOINE (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2023 6:06 AM | Centessa Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/14/2023 6:18 AM | Centessa Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/10/2023 4:00 PM | Centessa Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/03/2023 4:34 PM | Centessa Pharmaceuticals (Issuer) HUSSAIN IQBAL J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/03/2023 4:35 PM | Centessa Pharmaceuticals (Issuer) CHAO DAVID M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/03/2023 4:29 PM | Bush Tia L (Reporting) Centessa Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/03/2023 4:31 PM | Centessa Pharmaceuticals (Issuer) GRAINGER DAVID J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/03/2023 4:32 PM | Centessa Pharmaceuticals (Issuer) SAHA SAURABH (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Global crypto currency reset (41 major banks signed up) (Ad) Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project... Here's everything you need to know. |
07/03/2023 4:33 PM | Centessa Pharmaceuticals (Issuer) Weinhoff Gregory M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/03/2023 12:43 PM | Centessa Pharmaceuticals (Subject) YVER ANTOINE (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/26/2023 6:03 PM | Centessa Pharmaceuticals (Issuer) General Atlantic S.a r.l. (0001858361) (Reporting) General Atlantic Cooperatief U.A. (Reporting) General Atlantic Cooperatief, L.P. (Reporting) General Atlantic UM B.V. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2023 4:05 PM | Centessa Pharmaceuticals (Issuer) Hukkelhoven Mathias (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2023 4:07 PM | Centessa Pharmaceuticals (Issuer) Kulkarni Samarth (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2023 4:08 PM | Centessa Pharmaceuticals (Issuer) Stuckley Carol (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2023 4:09 PM | Centessa Pharmaceuticals (Issuer) ZBAR BRETT I W (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2023 4:01 PM | Centessa Pharmaceuticals (Issuer) Rotman Harris (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
06/23/2023 4:02 PM | Centessa Pharmaceuticals (Issuer) GOYAL ARJUN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2023 4:03 PM | Centessa Pharmaceuticals (Issuer) Hedley Mary Lynne (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/22/2023 3:05 PM | Centessa Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/09/2023 6:10 AM | Centessa Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/24/2023 4:06 PM | Bush Tia L (Reporting) Centessa Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/23/2023 3:08 PM | Centessa Pharmaceuticals (Filer)
| Form DEFA14A | |
05/22/2023 6:06 AM | Centessa Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/15/2023 7:00 AM | Centessa Pharmaceuticals (Filer)
| Form ARS | |
05/15/2023 7:01 AM | Centessa Pharmaceuticals (Filer)
| Form DEF 14A | |
05/12/2023 6:04 AM | Centessa Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/12/2023 6:14 AM | Centessa Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |